SMMT - NASDAQ

Summit Therapeutics Inc.

SMMT·NASDAQ

$15.07

+1.4%

HealthcareBiotechnology

Summit Therapeutics Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines to treat infectious diseases in the United States and Latin America. It conducts clinical programs focusing on Clostridioides difficile infection (CDI). The company's lead product candidate is ridinilazole, an orally administered small molecule antibiotic that is in Phase III clinical trials for the treatment of CDI. It also offers SMT-738, for combating multidrug resistant infections primarily carbapenem-resistant Enterobacteriaceae infections; and DDS-04 series for the potential treatment of infections caused by the Enterobacteriaceae. The company was founded in 2003 and is based in Cambridge, Massachusetts.

Statements Value Model

At a Glance

Live Snapshot

Market Cap$11.68B

EPS-1.4400

P/E Ratio-10.47

Earnings Date08/10/2026

smmt

Effect of Foreign Exchange Changes on Cash

Last Annual Value

102.00K

3-Year CAGR

28%

5-Year CAGR

-29%

10-Year CAGR

-5%

Adjust for Inflation

Summit Therapeutics Inc. Competitors Analysis of Effect of Foreign Exchange Changes on Cash

SMMT · NASDAQ

Company	Effect of Foreign Exchange Changes on Cash	CAGR 3Y	CAGR 5Y	CAGR 10Y
Summit Therapeutics Inc. NASDAQ:SMMT	102.00K	-50.5%	-21.9%	N/A
Atrium Therapeutics, Inc. NASDAQ:RNA	0.00	N/A	N/A	N/A
Ionis Pharmaceuticals, Inc. NASDAQ:IONS	702.00K	25.9%	N/A	N/A
Universal Health Services, Inc. NYSE:UHS	2.52M	-6.3%	N/A	N/A
Exact Sciences Corporation NASDAQ:EXAS	891.00K	-12.3%	107.8%	N/A
Moderna, Inc. NASDAQ:MRNA	2.00M	N/A	N/A	N/A
Royalty Pharma plc NASDAQ:RPRX	0.00	N/A	N/A	N/A
BridgeBio Pharma, Inc. NASDAQ:BBIO	0.00	N/A	N/A	N/A
Revolution Medicines, Inc. NASDAQ:RVMD	0.00	N/A	N/A	N/A

Summit Therapeutics Inc. Fair Value Envelope

SMMT · NASDAQ

Our analysis suggests that SMMT has a fair value of HIDDEN per share in the Base Case projection. With shares currently trading at $15.07, this represents a potential HIDDEN relative to our calculated worth for Summit Therapeutics Inc..

HIDDEN

Intrinsic Value

Current Price: $15.07

Related Guides

Blog Categories

Continue your SMMT research with focused valuation guides.

Fundamentals

Decode statement quality and operating durability.

Accounting

Interpret line items with cleaner analytical framing.

Forecasting

Translate historical performance into forward scenarios.

Reference

Use practical frameworks for statement-led valuation.

Research Paths

Pick your next lens

Snapshot

Start with context, operating signals, and key market metrics.

Value Model

Stress test fair value across bear, base, and bull assumptions.

Statements

Validate revenue quality, margins, and balance sheet durability.

Earnings Call

Read management commentary and compare it with reported outcomes.

Dividends

Check payout sustainability and long-term distribution behavior.

Analyst Expectations

Review consensus spread and where estimate risk is concentrated.